Inhibrx GAAP EPS -2.34 misses by 0.06; interest expense rises
Inhibrx reports GAAP EPS of -2.34, missing by 0.06, while interest expense jumps to $4.5M from $1.3M amid debt rising to $175M from $100M.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.